DE60235297D1 - Auf lps-reagierendes chs1/beige-ähnliches anker-gen und therapeutische anwendungen davon - Google Patents

Auf lps-reagierendes chs1/beige-ähnliches anker-gen und therapeutische anwendungen davon

Info

Publication number
DE60235297D1
DE60235297D1 DE60235297T DE60235297T DE60235297D1 DE 60235297 D1 DE60235297 D1 DE 60235297D1 DE 60235297 T DE60235297 T DE 60235297T DE 60235297 T DE60235297 T DE 60235297T DE 60235297 D1 DE60235297 D1 DE 60235297D1
Authority
DE
Germany
Prior art keywords
lrba
beige
lps
chs1
resistant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60235297T
Other languages
English (en)
Inventor
William G Kerr
Jia-Wang Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of South Florida
Original Assignee
University of South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of South Florida filed Critical University of South Florida
Application granted granted Critical
Publication of DE60235297D1 publication Critical patent/DE60235297D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60235297T 2001-04-02 2002-04-02 Auf lps-reagierendes chs1/beige-ähnliches anker-gen und therapeutische anwendungen davon Expired - Lifetime DE60235297D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28010701P 2001-04-02 2001-04-02
PCT/US2002/010350 WO2002078614A2 (en) 2001-04-02 2002-04-02 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof

Publications (1)

Publication Number Publication Date
DE60235297D1 true DE60235297D1 (de) 2010-03-25

Family

ID=23071704

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60235297T Expired - Lifetime DE60235297D1 (de) 2001-04-02 2002-04-02 Auf lps-reagierendes chs1/beige-ähnliches anker-gen und therapeutische anwendungen davon

Country Status (7)

Country Link
US (2) US7704963B2 (de)
EP (1) EP1383924B1 (de)
AT (1) ATE457359T1 (de)
AU (1) AU2002303214A1 (de)
CA (1) CA2443338A1 (de)
DE (1) DE60235297D1 (de)
WO (1) WO2002078614A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691821B2 (en) * 2001-09-19 2010-04-06 University Of South Florida Inhibition of SHIP to enhance stem cell harvest and transplantation
US20020165192A1 (en) * 2000-09-19 2002-11-07 Kerr William G. Control of NK cell function and survival by modulation of ship activity
US8440395B2 (en) * 2001-04-02 2013-05-14 University Of South Florida Methods of detecting and treating colon disorders
CA2443338A1 (en) * 2001-04-02 2002-10-10 University Of South Florida Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof
DE10229872A1 (de) * 2002-07-03 2004-01-29 Curevac Gmbh Immunstimulation durch chemisch modifizierte RNA
US20070224124A1 (en) * 2002-09-30 2007-09-27 University Of South Florida Novel SH2containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein
EP1554408A2 (de) * 2002-10-25 2005-07-20 Oncotherapy Science, Inc. Methode zur diagnose von undifferenziertem magenkrebs
US7807646B1 (en) * 2003-11-20 2010-10-05 University Of South Florida SHIP-deficiency to increase megakaryocyte progenitor production
US7763592B1 (en) 2003-11-20 2010-07-27 University Of South Florida SHIP-deficiency to increase megakaryocyte progenitor production
WO2007011819A2 (en) * 2005-07-15 2007-01-25 The Penn State Research Foundation Ferritin as a therapeutic target in abnormal cells
EP2046954A2 (de) 2006-07-31 2009-04-15 Curevac GmbH Nukleinsäure der formel (i): gixngn, oder (ii): cixmcn, insbesondere als immunstimulierendes mittel/adjuvans
WO2009030254A1 (en) 2007-09-04 2009-03-12 Curevac Gmbh Complexes of rna and cationic peptides for transfection and for immunostimulation
WO2009095226A2 (en) 2008-01-31 2009-08-06 Curevac Gmbh Nucleic acids of formula (i) (nuglxmgnnv)a and derivatives thereof as an immunostimulating agent/adjuvant
WO2010037408A1 (en) 2008-09-30 2010-04-08 Curevac Gmbh Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
US20110053829A1 (en) 2009-09-03 2011-03-03 Curevac Gmbh Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
US8968746B2 (en) 2010-07-30 2015-03-03 Curevac Gmbh Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
WO2013113326A1 (en) 2012-01-31 2013-08-08 Curevac Gmbh Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
US9738706B2 (en) * 2013-03-22 2017-08-22 University Of South Florida Inflammatory disease diagnosis and methods of treatment using lipopolysaccharides-responsive beige-like anchor
KR20160044566A (ko) 2013-08-21 2016-04-25 큐어백 아게 호흡기 세포융합 바이러스
EP3129050A2 (de) 2014-04-01 2017-02-15 CureVac AG Polymerträger-cargo-komplex zur verwendung als immunstimulierendes mittel oder als ein adjuvans
WO2016168848A1 (en) 2015-04-17 2016-10-20 University Of South Florida Animal model and method for studying gene-gene interactions
CN105238875A (zh) * 2015-11-19 2016-01-13 湖南宏雅基因技术有限公司 基于lrba基因检测抗ctla-4抗体药物疗效的试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789214A (en) 1988-03-08 1998-08-04 Novartis Finance Corporation Method of inducing gene transcription in a plant
US5614395A (en) 1988-03-08 1997-03-25 Ciba-Geigy Corporation Chemically regulatable and anti-pathogenic DNA sequences and uses thereof
US5639949A (en) 1990-08-20 1997-06-17 Ciba-Geigy Corporation Genes for the synthesis of antipathogenic substances
AU8914291A (en) 1990-11-23 1992-06-25 Plant Genetic Systems N.V. Process for transforming monocotyledonous plants
US5593874A (en) 1992-03-19 1997-01-14 Monsanto Company Enhanced expression in plants
US5693512A (en) 1996-03-01 1997-12-02 The Ohio State Research Foundation Method for transforming plant tissue by sonication
CA2443338A1 (en) * 2001-04-02 2002-10-10 University Of South Florida Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof
US8440395B2 (en) * 2001-04-02 2013-05-14 University Of South Florida Methods of detecting and treating colon disorders
US20110165566A1 (en) * 2009-07-09 2011-07-07 Wittliff James L Methods of optimizing treatment of breast cancer

Also Published As

Publication number Publication date
EP1383924A2 (de) 2004-01-28
EP1383924A4 (de) 2005-06-15
US7704963B2 (en) 2010-04-27
WO2002078614A2 (en) 2002-10-10
AU2002303214A1 (en) 2002-10-15
US20100266548A1 (en) 2010-10-21
ATE457359T1 (de) 2010-02-15
US20040235765A1 (en) 2004-11-25
CA2443338A1 (en) 2002-10-10
EP1383924B1 (de) 2010-02-10
WO2002078614A3 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
DE60235297D1 (de) Auf lps-reagierendes chs1/beige-ähnliches anker-gen und therapeutische anwendungen davon
DE60232870D1 (de) Neue polynukleotide und polypeptide des erythropoietingens
WO1999053040A3 (de) Menschliche nukleinsäuresequenzen aus ovartumorgewebe
IL158415A0 (en) NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha-17 GENE
ATE307886T1 (de) Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung
WO2002081745A3 (en) Genes involved in osteogenesis, and methods of use
ATE452184T1 (de) Mikrobielle trypsinvarianten mit chymotrypsinaktivität und diese codierende nukleinsäuren
WO1999046374A3 (de) Menschliche nukleinsäuresequenzen aus prostatatumorgewebe
WO2002095067A3 (en) INTERFERON α-14 POLYMORPHISM
WO2003000896A3 (en) POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE
WO1999046375A3 (de) Menschliche nukleinsäuresequenzen aus prostatagewebe
ATE500338T1 (de) Verwendung des adenoviralen e2-late-promotors
WO2004074491A3 (en) Expression in plants of antibodies against enterotoxigenic escherichia coli
NO20052525D0 (no) Spleisevariant av humant hypofyseveksthormon
EP1236800A3 (de) Für Interferon alfa 2 codierende Nukleinsäuren die Einzelnukleotidpolymorphismen enthalten und Methoden zu deren Verwendung
ATE417066T1 (de) Modifizierte cdna für hohe expressionsniveaus von faktor viii und dessen derivaten
WO2002060476A3 (de) Tumorvakzine
WO2002083733A3 (en) Polynucleotides and polypeptides of the ifnalpha-6 gene
WO2002101002A3 (en) Identification of snps the hgv-v gene
DE60222669D1 (de) Asthma-assoziiertes gen
ATE328082T1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
WO2005049818A3 (en) Genes encoding human deubiquitinating enzymes
EP1329504A4 (de) Nukleinsäure eines neuen menschlichen kinesin-assoziierten gens, von der nukleinsäure kodiertes protein, peptidfragment davon sowie die nukleinsäure und ähnliches enthaltende antikrebsmittel
WO2003040320A3 (en) Antisense modulation of human collapsin response mediator protein 2 expression
WO2004089980A3 (en) Therapeutic cancer vaccine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition